Products found to contain undeclared medicines
|
| |
| The United States: F&S Medical Supply, DBA Pink Toyz Issues Voluntary Nationwide Recall of Pink Pussycat Capsules Due to the Presence of Undeclared Sildenafil |
| |
The US Food and Drug Administration (FDA) announces that F&S Medical Supply, dba Pink Toyz is voluntarily recalling one lot of Pink Pussycat 3000 mg capsules to the consumer level. FDA analysis has found the product Pink Pussycat to be tainted with sildenafil, an ingredient known as a phosphodiesterase (PDE-5) inhibitor found in an FDA approved product for the treatment of male erectile dysfunction. The presence of sildenafil in Pink Pussycat capsules renders the product an unapproved drug for which the safety and efficacy have not been established and, therefore, subject to recall.
Consumers with underlying medical conditions who take Pink Pussycat with undeclared sildenafil may experience serious health risks. For example, PDE-5 inhibitors may interact with nitrates found in some prescription drugs (such as nitroglycerin) lowering blood pressure to dangerous levels that may be life-threatening. Consumers with diabetes, high blood pressure, or heart disease often take nitrates. To date, 03/30/2022, Pink Toyz has not received any reports of adverse events related to this recall.
Pink Pussycat Capsules are marketed as a dietary supplement for male sexual enhancement.
Please refer to the following website in FDA for details:
http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/fs-medical-supply-dba-pink-toyz-issues-voluntary-nationwide-recall-pink-pussycat-capsules-due
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/ Saturday, 2 Apr, 2022
Issued at HKT 13:00
|
| |
